XXXX paraesthetica: Ultrasound-guided injection at multiple levels with 12-month follow-up.

@entity1 @entity64296 @entity16 @entity19140 @entity230
OBJECTIVES: To evaluate the efficacy of ultrasound (US)-guided injections around the lateral femoral cutaneous nerve (LFCN) at different levels in @entity64296 ( @entity64296 ) @entity1 . METHODS: The study was approved by the university ethics committee and informed oral and written consent were obtained from all @entity1 . Between June 2008 and August 2013, 20 @entity1 with symptoms of @entity64296 , including nine @entity1 (mean age, 61.33 years) and 11 @entity1 (mean age 61.18 years), were treated with US-guided injection of @entity230 along the LFCN at three different levels in a mean of 2.25 sessions. A visual analogue scale (VAS) was used to measure symptoms before, immediately after and 12 months after treatment. RESULTS: Complete resolution of symptoms was documented in 15/20 @entity1 (mean VAS decreased from 82 to 0), and partial resolution in the remaining five (mean VAS decreased from 92 to 42), which was confirmed at 12-month follow-up. By using the different levels of injection approach overall significantly better symptom relief was obtained (p   <   0.05). CONCLUSION: The outcome of US-guided injection along the LFCN can be further improved by injections at different levels (p   <   0.05), which was confirmed at 12-month long-term follow-up. KEY POINTS: @entity19140 paraesthetica is an @entity16 of the lateral femoral cutaneous nerve. Ultrasound proved effective in diagnosis and in guiding injection therapy. Injection at the anterior superior iliac spine has been used previously. Multiple injections along the nerve course were used in this study. Long-term follow-up (12 months) confirmed the results.
